Making the discoveries that defeat cancer

  • Home »
  • Research »
  • Repository

  • Administrators Login

  • Repository Homepage
  • About the Repository
  • Browse the Repository
  • Search the Repository
  • Contribute an Article
  • Missing Publications
  • Repository Help

Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies

Tools
- Tools
+ Tools

Whittaker, S., Kirk, R., Hayward, R., Zambon, A., Viros, A., Cantarino, N., Affolter, A., Nourry, A., Niculescu-Duvaz, D., Springer, C., Marais, R. (2010) Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies. Science Translational Medicine, 2 (35). ISSN 1946-6234

Full text not available from this repository.

Item Type: Article
Authors (ICR Faculty only): Marais, Richard and Springer, Caroline and Niculescu-Duvaz, Dan
All Authors: Whittaker, S., Kirk, R., Hayward, R., Zambon, A., Viros, A., Cantarino, N., Affolter, A., Nourry, A., Niculescu-Duvaz, D., Springer, C., Marais, R.
Additional Information: ISI Document Delivery No.: 735OL Times Cited: 6 Cited Reference Count: 42 Whittaker, Steven Kirk, Ruth Hayward, Robert Zambon, Alfonso Viros, Amaya Cantarino, Neus Affolter, Annette Nourry, Arnaud Niculescu-Duvaz, Dan Springer, Caroline Marais, Richard Amer assoc advancement science Washington
Uncontrolled Keywords: randomized discontinuation trial chronic myelogenous leukemia signal-regulated kinase renal-cell carcinoma b-raf cytogenetic responses phase-ii therapeutic target tyrosine kinases oncogenic braf
Research teams: Closed research groups > Signal Transduction
ICR divisions > Cancer Therapeutics > Gene & Oncogene Targeting
Depositing User: Barry Jenkins
Date Deposited: 05 Apr 2011 10:21
Last Modified: 08 Nov 2012 15:58
URI: http://publications.icr.ac.uk/id/eprint/10619

Actions (login required)

View Item View Item
The Royal Marsden - NHS foundation trust